Code
365K7809
Duration
01 June 2009 → 31 December 2012
Funding
Funding by bilateral agreement (private and foundations)
Promotor
Research disciplines
-
Natural sciences
- Geology
- Genetics
- Systems biology
- Aquatic sciences, challenges and pollution
-
Medical and health sciences
- Hematology
- Laboratory medicine
- Molecular and cell biology
- Morphological sciences
- Oncology
- Pediatrics and neonatology
- Hematology
- Laboratory medicine
- Morphological sciences
- Oncology
- Pediatrics and neonatology
- Nursing
- Hematology
- Laboratory medicine
- Molecular and cell biology
- Morphological sciences
- Oncology
- Pediatrics and neonatology
Keywords
neuroblastoma
gene expression signatures
Risk classification
Project description
Neuroblastoma is a solid cancer, diagnosed in children under 15 years and is responsible for 15% of cancer deaths in children. Neuroblastoma is characterized by a remarkable clinical and genetic heterogeneity. In this project, gene-expression signatures are being studied for accurate risk classification of neuroblastoma patients. This will allow clinicians to select for risk-related therapies, leading to increased effectiveness of cancer treatment and increse in survival rates.